Evidence map›Paper›PMID 39510068›Full record

ArticleImmunity2024

Maintenance and functional regulation of immune memory to COVID-19 vaccines in tissues.

Julia Davis-Porada, Alex B George, Nora Lam, Daniel P Caron, Joshua I Gray, Jenny Huang, Jennifer Hwu, Steven B Wells, Rei Matsumoto, Masaru Kubota and 12 more

Abstract read
In one paragraph

Article in Immunity, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Julia Davis-PoradaDepartment of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY 10032, USA; Medical Scientist Training Program, Columbia University Irving Medical Center, New York, NY 10032, USA.
Alex B GeorgeMedical Scientist Training Program, Columbia University Irving Medical Center, New York, NY 10032, USA; Department of Systems Biology, Columbia University Irving Medical Center, New York, NY 10032, USA.
Nora LamDepartment of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY 10032, USA; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032, USA.
Daniel P CaronDepartment of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY 10032, USA.
Joshua I GrayDepartment of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY 10032, USA.
Jenny HuangDepartment of Systems Biology, Columbia University Irving Medical Center, New York, NY 10032, USA.
Jennifer HwuDepartment of Systems Biology, Columbia University Irving Medical Center, New York, NY 10032, USA.
Steven B WellsDepartment of Systems Biology, Columbia University Irving Medical Center, New York, NY 10032, USA.
Rei MatsumotoDepartment of Surgery, Columbia University Irving Medical Center, New York, NY 10032, USA.
Masaru KubotaDepartment of Surgery, Columbia University Irving Medical Center, New York, NY 10032, USA.
YoonSeung LeeDepartment of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY 10032, USA.
Rory Morrison-ColvinDepartment of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY 10032, USA.
Isaac J JensenDepartment of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY 10032, USA.
Basak B UralDepartment of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY 10032, USA.
Namir ShaabaniDepartment of Immunology and Microbiology, Scripps Research, La Jolla, CA 92037, USA.
Daniela WeiskopfCenter of Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
Alba GrifoniCenter of Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
Alessandro SetteCenter of Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA; Department of Pathology, University of California, San Diego, La Jolla, CA 92093, USA.
Peter A SzaboDepartment of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY 10032, USA.
John R TeijaroDepartment of Immunology and Microbiology, Scripps Research, La Jolla, CA 92037, USA.
Peter A SimsDepartment of Systems Biology, Columbia University Irving Medical Center, New York, NY 10032, USA; Department of Biochemistry and Molecular Biophysics, Columbia University Irving Medical Center, New York, NY 10032, USA. Electronic address: pas2182@cumc.columbia.edu.
Donna L FarberDepartment of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY 10032, USA; Department of Surgery, Columbia University Irving Medical Center, New York, NY 10032, USA. Electronic address: df2396@cumc.columbia.edu.

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Parisa Tehranifar · 1985 to 2026
$115.3M
VACCINE INDUCED IMMUNITY IN THE YOUNG AND AGEDU19AI057266 · NIAID · EMORY UNIVERSITY · PI Rafi Ahmed · 2003 to 2026
$81.7M
Transcriptomics and Repertoire ProfilingP01AI106697 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Ryan Gilbert Gaudet · 2013 to 2026
$31.3M
Viral Assays CoreU19AI128949 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Donna L. Farber, Peter Alan Sims · 2017 to 2026
$26.4M
Large Scale T Cell Epitope Discovery:Global identification of epitopes derived from Zika (ZIKV), Chikungunya (CHIKV) viruses following natural infection and vaccination75N93019C00065 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI MITCHELL, MAYA · 2019 to 2023
$7.3M
Medical Scientist Training ProgramT32GM145440 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI STEVEN L REINER · 2022 to 2026
$7.3M
The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccinationR01AI167372 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI Donna L. Farber, John Ross Teijaro · 2022 to 2026
$4.4M
Columbia University Graduate Training Program in Microbiology and ImmunologyT32AI106711 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Nicholas Arpaia, Uttiya Basu · 2014 to 2026
$2.1M
Five-laser Aurora spectral flow cytometerS10OD030282 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CREUSOT, REMI J · 2022 to 2022
$361k
Induction and maintenance of SARS-CoV-2 mRNA vaccine-specific memory across tissuesF30AI174785 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Julia Meghan Davis-Porada · 2023 to 2026
$210k
NCI NIH HHS P30 CA013696NIAID NIH HHS 75N93019C00065NIAID NIH HHS F30 AI174785NIAID NIH HHS P01 AI106697NIAID NIH HHS R01 AI167372NIAID NIH HHS T32 AI106711NIAID NIH HHS U19 AI057266NIAID NIH HHS U19 AI128949NIGMS NIH HHS T32 GM145440NIH HHS S10 OD030282
6 · The paper itself

Abstract

Memory T and B cells in tissues are essential for protective immunity. Here, we performed a comprehensive analysis of the tissue distribution, phenotype, durability, and transcriptional profile of COVID-19 mRNA vaccine-induced immune memory across blood, lymphoid organs, and lungs obtained from 63 vaccinated organ donors aged 23-86, some of whom experienced SARS-CoV-2 infection. Spike (S)-reactive memory T cells were detected in lymphoid organs and lungs and variably expressed tissue-resident markers based on infection history, and S-reactive B cells comprised class-switched memory cells resident in lymphoid organs. Compared with blood, S-reactive tissue memory T cells persisted for longer times post-vaccination and were more prevalent with age. S-reactive T cells displayed site-specific subset compositions and functions: regulatory cell profiles were enriched in tissues, while effector and cytolytic profiles were more abundant in circulation. Our findings reveal functional compartmentalization of vaccine-induced T cell memory where surveilling effectors and in situ regulatory responses confer protection with minimal tissue damage.

Indexed as

COVID-19COVID-19 VaccinesImmunologic MemoryMemory T CellsSARS-CoV-2AdultAgedAged, 80 and overB-LymphocytesFemaleHumansLungLymphoid TissueMaleMiddle AgedSpike Glycoprotein, CoronavirusCOVID-19 VaccinesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2COVID-19human immunologyimmunologic memorylung immunitylymphoid organsmemory B cellsmRNA vaccinesregulatory T cellsSARS-CoV-2tissue-resident memory T cells

Identifiers

PMID39510068
PMCPMC11634668

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.